Abstract
Recent evidence from animal studies has raised the possibility that immunisation by vaccines can influence the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. In non-obese diabetic mice and biobreeding rats, complete Freund’s adjuvant and bacillus Calmette-Guérin (BCG) vaccine have successfully been used to interrupt the development of diabetes mellitus. This effect is probably mediated by nonspecific suppression of the autoimmune process. A number of attempts have also been made to assess the impact of parenteral immunisation on type 1 diabetes mellitus in humans.
Epidemiological evidence has not indicated any clear link between BCG vaccination and the development of diabetes mellitus in humans. Some reports have suggested that natural mumps or mumps vaccinations can induce islet cell auto-immunity, but there is no evidence that mumps-measles-rubella mass vaccination programmes have changed the incidence of diabetes mellitus in any population. An independent protective role of measles virus has been suggested in one study. Recent studies have indicated that enterovirus infections may induce β cell auto-immunity and clinical diabetes. The only currently available enterovirus vaccine is the poliovirus vaccine which, in theory, could modulate the protection against other enteroviruses by inducing cross-reactive T cell immune responses; however, this hypothesis has not been tested so far.
In conclusion, there is no clear evidence that any currently used vaccine can prevent or induce diabetes in humans. However, only a few studies are available on the subject and therefore the possibility of a link between vaccination and diabetes mellitus cannot be excluded.
Similar content being viewed by others
References
Karvonen M, Tuomilehto J, Libman I. The World Health Organisation DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 833–92
Rewers M, Atkinson M. The possible role of enteroviruses in diabetes mellitus. In: Rotbart HA, editor. Human enterovirus infections. Washington (DC): American Society for Microbiology, 1995: 353–85
Vardi P. Adjuvant administration modulates the process of beta-cell autoimmunity and prevents IDDM: introduction to human trials. Diabetes Metab Rev 1993; 9: 317–22
Sadelain MWJ, Qin H-Y, Lauzon J, et al. Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990; 39: 583–9
Harada M, Kishimoto Y, Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 1990; 8: 85–89
Yagi H, Matsumoto M, Kishimoto Y, et al. Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse: II: suppression of pathogenesis by macrophage transfer from BCG-vaccinated mice. Cell Immunol 1991; 138: 142–9
Wang T, Singh B, Warnock GL, et al. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant therapy. Diabetes 1992; 41: 114
Lakey JRT, Singh B, Warnock GL, et al. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. Transplantation 1994; 57: 1213–7
Baxter AG, Horsfall AC, Healey D, et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994; 83: 227–31
Gazda L, Baxter AG, Lafferty KJ. Regulation of autoimmune diabetes: characteristics of non-islet-antigen specific therapies. Immunol Cell Biol 1996; 74: 401–7
Qin H Y, Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophophamide. J Autoimmun 1997; 10: 271–8
Huang S-W, Taylor G, Basid A. The effect of pertussigen vaccine on the insulin-dependent diabetes induced by streptozotocin in mice. Pediatr Res 1984; 18: 221–6
Huang S-W, Luchetta R, Peck AB. Pertussigen treatment retards, but fails to prevent, the development of type 1, insulin-dependent diabetes mellitus (IDDM) in NOD mice. Autoimmunity 1991; 9: 311–7
Ramiya VK, Shang X-Z, Pharis PG, et al. Antigen based therapies to prevent diabetes in NOD mice. J Autoimmun 1996; 9: 349–56
Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996; 24: 137–45
Smerdon RA, Peakman M, Hussain MJ, et al. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology 1993; 80: 498–501
Shehadeh N, Calcinaro F, Bradley BJ, et al. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 1994; 343: 706–7
Pozzilli P, IMDIAB Group. BCG vaccine in insulin-dependent diabetes mellitus. Lancet 1997; 349: 1520–1
Dahlquist G, Gothefors L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination [letter]. Diabetologia 1995; 38: 874
Classen JB, Classsen DC. Vaccines modulate IDDM. Diabetologia 1996; 39: 500–2
Parent M-E, Fritschi L, Siemiatycki J, et al. Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada. Diabetes Care 1997; 20: 767–72
Sinaniotis CA, Daskalopoulou E, Lapatsanis P, et al. Diabetes mellitus after mumps vaccination [letter]. Arch Dis Child 1975; 50: 749–50
Helmke K, Otten A, Willems W. Islet cell antibodies in children with mumps infection [letter]. Lancet 1980; II: 211–2
Helmke K, Otten A, Willems WR, et al. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 1986; 29: 30–3
Ratzmann KP, Strese J, Witt S, et al. Mumps infection and insulin-dependent diabetes mellitus (IDDM). Diabetes Care 1984; 7: 170–3
Federlin K, Otten A, Helmke A. Islet cell antibodies and viral infections. Exp Clin Endocrinol 1987; 89: 368–74
Hummel M, Ziegler A-G, BABY-DIAB Study. Vaccines and the appearance of islet cell antibodies in offspring of diabetic parents. Diabetes Care 1996; 19: 1456–7
Hyöty H, Hiltunen M, Reunanen A, et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993; 36: 1303–8
Hiltunen M, Hyöty H, Leinikki P, et al. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children. Diabet Med 1994; 11: 942–6
Blom L, Nyström L, Dahlquist G, the Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991; 34: 176–81
Hejbel H, Chen RT, Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care 1997; 20: 173–5
Hyöty H, Hiltunen M, Knip M, the Childhood Diabetes in Finland (DiMe) Study group. A prospective study of the role of coxsackie B virus and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652–7
Hiltunen M, Hyöty H, Knip M, the Childhood Diabetes in Finland (DiMe) Study Group. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997; 175: 554–60
Juhela S, Hyöty H, Lönnrot M, et al. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol 1998; 54: 226–32
Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996; 9: 699–703
Singh B. Possible immunological treatment for type 1 diabetes in the 21st century. Pract Diabetes Int 1997; 14: 197–200
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hiltunen, M., Lönnrot, M. & Hyöty, H. Immunisation and Type 1 Diabetes Mellitus. Drug-Safety 20, 207–212 (1999). https://doi.org/10.2165/00002018-199920030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199920030-00001